Navigation Links
Artielle ImmunoTherapeutics Announces Positive Results of Phase 1 Multiple Sclerosis Trial
Date:9/14/2009

platform is the subject of an exclusive worldwide license from Oregon Health & Science University and is protected by multiple issued US and foreign patents and patent applications. For more information please visit www.artielle.com


'/>"/>
SOURCE Artielle ImmunoTherapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
2. BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
3. BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...all/--ERT(Nasdaq: ERES ),announcedtodaythatDr.Mich...Schneck,theCompany,sExecutiveVicePresidentandCFO,a...lthCareConferenceat1:30PMESTonDecember1,2009inNewY...hepresentationbyvisitingtheCompany,scorporatewebsi...edat http://www.corporate-ir.net/ireye/conflobby.z...
(Date:11/25/2009)...TheFDAgrantedtraditionalapprovalforINTELENCE®...ptaseinhibitor(NNRTI).INTELENCEistheonlyNNRTIspeci...swhoareexperiencingvirologicfailurewithHIV-1strain...ts.Thetraditionalapprovalisbasedon48-weekdatafromt...urrentlymarketedintheU.S.byTibotecTherapeutics,adi...
(Date:11/25/2009)...e/--AMPACFineChemicalsLLC(AFC),asubsidiaryofAmeric...hatitreceivedtheEnvironmentalResponsibilityandSust...mmit,sponsoredbytheCaliforniaManufacturersandTechn...ssociation(IEA)andtheChemicalIndustryCouncilofCali...sawardavailablefromallthreeorganizationsandgainssu...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Tattoo Removal on the Fastest U S Marine 62003 1Tattoo Removal on the Fastest U S Marine 62003 2FloatScope A New Device for Self Viewing Eye Floaters 62001 1FloatScope A New Device for Self Viewing Eye Floaters 62001 2Cell Therapeutics Inc 28CTI 29 to Present at 21st Annual Piper Jaffray Health Care Conference 14951 1
...to Reduced Premature Births, WATSONVILLE, Calif.,...study that shows folic acid supplements greatly,re...ral health officials,say not enough women are taki... to remember to take vitamins, but women (and,men)... visit their,supermarket,s produce aisle or farmer...
.... 5 Joseph F. Finn, Jr.,CPA, the Assignee for the...oday that The Committee for Orphan Drug Products o... Orphan Drug Designation for M40403 for the,preven...r patients,receiving radiotherapy., The developme...ead and,neck cancers is the major reason for poor ...
Other Medicine Technology:Folate in Strawberries May Contribute to Healthy Pregnancy 2ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication 2ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication 3
(Date:11/26/2009)... In the next 25 years, the number of Americans li...from 23.7 million in 2009 to 44.1 million in 2034....lmost triple, rising from $113 billion to $336 bil...besity, researchers based at the University of Chi...e . , The number of those with diabetes covered ...
(Date:11/26/2009)... Dr. David Kim of the Liv...oss surgery in Dallas , is one of a growing number...r social networking sites to connect with individu...atment to fight morbid obesity. Dr. Kim is utilizi...nformation about his practice with the community. ...
(Date:11/25/2009)...,, KANSASCITY,Mo.,Nov.25/PRNewswire/--TheBart...on,slargestmedicalcliniconDec.9-10,whenKansasCityh...uredpeople. ,, "Thisfreecliniceventhasthepotent...daysinsteadofjustoneandbeheldonweekdaysinsteadofov...CityFreeHealthClinicandpresidentoftheNationalAssoc...
(Date:11/25/2009)...,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNewsw...DA,sCenterforDrugEvaluationandResearch,titled"ADif..."appearsintheNov.26,2009issueofTheNewEnglandJourna...gi-bin/prnh/20090824/FDALOGO ) ,, Inthearticle,...accesstopainmedicationforthosewhoneeditandmanaging...
(Date:11/25/2009)... Researchers have found evidence of a statistical...xifen among patients whose estrogen receptor (ER)-... of ER-alpha; at serine-118 (ER-alpha S118-P), acc...ovember 25 in the Journal of the National Cancer ...omas are resistant to tamoxifen. Preclinical studi...
Breaking Medicine News(10 mins):Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2
...de this summer when the U.S. Food and Drug Adminis...t cervical cancer//. The vaccine was given the gre...tect against human papillomavirus (HPV), a sexuall...the Society for Women’s Health Research and chair ...
...istributed to cope with a major influenza pandemic...e of the Medical Journal of Australia. // As...Sydney GP Dr Nick Collins and colleagues outlined ...es are recognised in some rural and outer metropol...
...re attending to babies born to drug-addicted mothe... before the babies are discharged from the hospita... treatment for drug addictions at the hospital ann...es in the special care nursery because they show s...
...ene that could possibly be the reason behind breas...taking a turn for the worse. // Melbourne sci...n mice discovered that a gene known as body morpho...ich was capable of offsetting breast tumors from b...
...rs, like hemophilia, is being used to control blee... The drug Recombinant Activated Factor VIII has ...ions in non-hemophiliacs. It can cause heart attac...d loss. Jawed Fareed an expert in blood clotti...
...al Devon and Exeter Hospital postulates that the f...//Mothers seem to determine how plump babies final... the researchers say that results derived so far, ...y, babies of mothers who are plump were seen to ha...
Other Medicine News:Health News:Triumphs and Hurdles for the New HPV Vaccine 2Health News:Triumphs and Hurdles for the New HPV Vaccine 3
INSIGNIA Ultra SR
...88 active-fixation leads are among the world's thi...g the unsurpassed handling advantages, performance...ne of active-fixation leads. Implantable with a 7 ...dril SDX lead is designed to lower the incidence o...
Veriteq's Refrigerator and Freezer Monitoring System
Aegis Checkpoint Temperature Reporting and Alarm System
Medicine Products: